Microarray vs RNA‑seq: Who Wins the Gene Expression Challenge?

Understanding which genes turn on or off is key to decoding how cells work. Today, RNA‑seq is the most popular method, but the older microarray is still in the race. Researchers compared the two approaches on blood samples from 35 teenagers involved in an HIV study. After extracting RNA, they processed the data using the same non‑parametric statistic, the Mann‑Whitney test. The results? Gene expression profiles are very similar: the average Pearson correlation coefficient is 0.76. RNA‑seq identified 2,395 differentially expressed genes, while microarray found 427; 223 genes were detected by both. Biological pathways also overlapped: 205 pathways with RNA‑seq, 47 with microarray, and 30 shared. In practice, when consistent statistical methods are used, the two tools give concordant results. This means microarray isn’t obsolete: it can still complement RNA‑seq, making analyses more robust and confirming findings. For young scientists, the lesson is clear: choosing the right tool and applying proper statistics matters more than “new vs old”.

The comparative analysis between microarray and RNA‑seq rests on two distinct technological philosophies. Microarrays employ probes fixed on a solid matrix; hybridization of the sample RNA generates a fluorescence signal proportional to transcript abundance. This approach is limited by reliance on predefined sequences and a narrower dynamic range, yet offers low cost and good reproducibility. RNA‑seq, by contrast, leverages massive sequencing of cDNA synthesized from total RNA, enabling discovery of novel transcripts, alternative isoforms, and splicing variants. Its sensitivity is higher, but it demands greater computational power for alignment and quantification. In this study, the choice of a non‑parametric test (Mann‑Whitney) is crucial because expression data often deviate from normality, violating parametric test assumptions. The Pearson correlation (r = 0.76) indicates strong concordance, yet correlation does not capture scale differences: RNA‑seq can detect subtler variations, explaining the larger number of differentially expressed genes (DEGs). Pathway enrichment analysis was likely performed with algorithms such as GSEA or DAVID, assessing overlap between DEG lists and annotated gene sets. The sharing of 30 pathways suggests that, despite methodological differences, biological conclusions remain robust. Future multi‑omics integration (transcriptomics, epigenomics, proteomics) could benefit from hybrid approaches, where microarrays provide rapid, low‑cost validation while RNA‑seq delves into transcriptional complexity. Moreover, employing advanced statistical methods like generalized linear models or bootstrapping can further improve cross‑platform comparability, reducing false positives and boosting overall statistical power.